Hospital Universitario Vall d'Hebron

Horta-Guinardó, Barcelona 8035

1 studies enrolling now · 2 studies all time

What they study most

Antibody-mediated Rejection, Symptomatic Genetic Dilated Cardiomyopathy

Studies at this site

• A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy — Recruiting now
• A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) — Running, not enrolling